Aurinia Pharmaceuticals (GB:0UJF)

Aurinia Pharmaceuticals (GB:0UJF) Income Statement


Aurinia Pharmaceuticals Income Statement

Last quarter (Q2 2022), Aurinia Pharmaceuticals's total revenue was $28.19M, an increase of 325.85% from the same quarter last year. In Q2, Aurinia Pharmaceuticals's net income was $-35.52M. See Aurinia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 87.89M$ 45.60M$ 50.12M$ 318.00K$ 463.00K$ 418.00K
Cost of Revenue
$ 2.59M$ 1.09M$ 0.00$ 52.87M$ 41.38M$ 33.93M
Gross Profit
$ 85.30M$ 44.51M$ 50.12M$ -52.55M$ -40.92M$ -33.51M
Operating Expense
$ 242.23M$ 225.25M$ 154.41M$ 76.34M$ 14.99M$ 13.55M
Operating Income
$ -156.93M$ -180.74M$ -104.29M$ -76.02M$ -55.91M$ -47.06M
Net Non Operating Interest Income Expense
$ 960.00K$ 529.00K$ 1.52M$ 2.70M$ 2.23M$ 702.00K
Other Income Expense
--$ -6.81M$ -14.92M$ 666.00K$ -24.43M
Pretax Income
$ -155.97M$ -180.21M$ -102.77M$ -88.24M$ -53.01M$ -70.79M
Tax Provision
$ 753.00K$ 760.00K$ -94.00K$ 144.00K$ 73.00K$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -156.72M$ -180.97M$ -102.68M$ -88.39M$ -53.08M$ -70.79M
Basic EPS
$ -1.16$ -1.40$ -0.87$ -1.33$ -0.63$ -0.92
Diluted EPS
$ -1.16$ -1.40$ -0.87$ -1.33$ -0.63$ -0.92
Basic Average Shares
$ 545.40M$ 129.37M$ 118.47M$ 93.02M$ 84.78M$ 76.92M
Diluted Average Shares
$ 545.40M$ 129.37M$ 118.47M$ 93.02M$ 84.78M$ 76.92M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
---$ 2.36M$ 1.70M$ 1.33M
Total Expenses
$ 244.82M$ 226.34M$ 154.41M$ 76.34M$ 56.37M$ 47.48M
Net Income From Continuing And Discontinued Operation
$ -156.72M$ -180.97M$ -102.68M$ -88.39M$ -53.08M$ -70.79M
Normalized Income
$ -156.72M$ -180.97M$ -102.68M$ -88.39M$ -53.08M$ -46.36M
Interest Expense
---$ 39.00K$ 0.00-
$ -156.93M$ -180.74M$ -104.29M$ -76.02M$ -55.91M$ -47.06M
$ -153.88M$ -177.97M$ -102.92M$ -74.85M$ -54.59M$ -45.61M
Currency in USD

Aurinia Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis